Novel antibacterial compounds

This invention relates to a novel purified compound PM181104, of formula (I) of molecular weight 1514 and molecular formula CHNOS; which is obtained by fermentation of the microorganism belonging to Kocuria species (ZMA B-1 / MTCC 5269). The invention includes all stereoisomeric forms and all tautom...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SAWANT, SATISH NAMDEO, MAHAJAN, GIRISH BADRINATH, NAIK, CHANDRAKANT GOVIND, EYYAMMADICHIYIL, SREEKUMAR SANKARANARAYANAN, MISHRA, PRABHU DUTT SATYANARAYAN, VISHWAKARMA, RAM, GEORGE, SAJI DAVID, DEVI, PRABHA, KRISHNA, SRIDEVI, PATEL, ZARINE ERUCH, RANADIVE, PRAFULL VASANT, PARI, KOTEPPA, PANSHIKAR, RAJAN MUKUND, THOMAS, BECKY MARY, D'SOUZA, LISETTE, SIVAKUMAR, MEENAKSHI
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This invention relates to a novel purified compound PM181104, of formula (I) of molecular weight 1514 and molecular formula CHNOS; which is obtained by fermentation of the microorganism belonging to Kocuria species (ZMA B-1 / MTCC 5269). The invention includes all stereoisomeric forms and all tautomeric forms of the compound PM181104 and pharmaceutically acceptable salts and derivatives such as esters and ethers. The present invention further relates to processes for the production of the novel antibacterial compound(s), to the production of the microorganism belonging to Kocuria species (ZMA B-1 / MTCC 5269), and to pharmaceutical compositions containing the novel compound(s) as an active ingredient and its/their use in medicines for treatment and prevention of diseases caused by bacterial infections.